Biological aspects of depression

Area of Science:

• Neuroendocrinology
• Psychiatry
• Pharmacology

Background:

• Neuroendocrine studies indicate differences in growth hormone (GH) release among patient groups.
• The clonidine-growth hormone stimulation test is used to assess neuroendocrine function.

Purpose of the Study:

• To investigate the GH response to clonidine in endogenous depressive patients.
• To explore the potential of GH response as a trait marker for endogenous depression.
• To examine the role of alpha 2-adrenoceptor sensitivity in depression.

Main Methods:

• Utilized the clonidine-growth hormone stimulation test.
• Compared GH response in endogenous depressives, neurotic depressives, schizophrenics, and controls.

Main Results:

• Endogenous depressive patients exhibited a significantly reduced GH response to clonidine compared to other groups.
• This blunted GH response suggests a potential trait marker or vulnerability factor for endogenous depression.
• The findings may be explained by reduced postsynaptic alpha 2-adrenoceptor sensitivity.

Conclusions:

• A blunted GH response to clonidine is a potential biomarker for endogenous depression.
• Reduced alpha 2-adrenoceptor sensitivity is implicated in the pathophysiology of endogenous depression.
• Endorphinergic and cholinergic systems may influence alpha 2-adrenoceptor sensitivity in depression.